相关实验视频

Updated: Aug 4, 2026

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

Published on: March 17, 2020

小细胞肺癌分析:对亚型,脆弱性和可塑性的更新综合

Esther Redin¹, Álvaro Quintanal-Villalonga¹, Charles M Rudin²

¹Department of Medicine, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Trends in cancer

|August 20, 2024

概括

小细胞肺癌 (SCLC) 亚型正在演变,由瘤和外部因素驱动. 了解亚型可塑性是开发这种侵袭性癌症的持久治疗的关键.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
癌症研究癌症研究

背景情况:

小细胞肺癌 (SCLC) 是具有高转移潜力的侵略性.
传统上由转录因子定义的SCLC亚型正在重新定义.
瘤的可塑性和异质性使SCLC的治疗和进展复杂化.

研究的目的:

审查最近在SCLC亚型分类方面的进展.
讨论这些新分类的生物学和临床影响.
突出塑性在SCLC进展和治疗耐药性的作用.

主要方法:

关于SCLC亚型的最近研究的文献综述.
分析与SCLC异质性相关的分子和转录数据.
检查针对SCLC可塑性的治疗策略.

主要成果:

新兴的SCLC亚型包括内在因素和外在因素.
在SCLC中存在显著的内异质性和转录性可塑性.
塑性影响疾病的进展和治疗耐药性.

结论:

新的SCLC亚型分类提供了更深入的生物学见解.
准可塑性和细胞命运转变提供了新的治疗途径.
对SCLC亚型和可塑性的进一步研究对于改善患者的治疗结果至关重要.

关键词:

在SCLC中,SCLC是最重要的.分子亚型分子亚型塑性的可塑性塑性治疗的脆弱性治疗的脆弱性

更多相关视频

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

相关概念视频

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...